South San Francisco, California-based Pliant Therapeutics is slated to debut on the Nasdaq Global Market, under the symbol 'PLRX', on June 3, 2020. Founded in 2016, Pliant Therapeutics is a clinical stage biopharmaceutical company developing novel therapies for the treatment of fibrosis.
from RTT - Biotech https://ift.tt/2zJGDao
via IFTTT
No comments:
Post a Comment